Advertisement

Topics

Indivior legal costs rise, new anti-addiction drug ready

22:15 EST 14 Feb 2018 | Reuters

LONDON (Reuters) - Britain's Indivior, which makes drugs to treat opioid addiction and plans to launch a key new product this month, said on Thursday it had increased provisions for investigative and antitrust litigation matters to $438 million.

Original Article: Indivior legal costs rise, new anti-addiction drug ready

NEXT ARTICLE

More From BioPortfolio on "Indivior legal costs rise, new anti-addiction drug ready"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...